1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia-Pacific Blood Transfusion Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia-Pacific Blood Transfusion Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia-Pacific Blood Transfusion Diagnostics Market Regional Analysis
6.2 Asia-Pacific Blood Transfusion Diagnostics Market Revenue 2020-2028 (US$ Million)
6.3 Asia-Pacific Blood Transfusion Diagnostics Market Forecast Analysis
7. Asia-Pacific Blood Transfusion Diagnostics Market Analysis – by Product
7.1 Instruments & Kits
- 7.1.1 Overview
- 7.1.2 Instruments & Kits: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Reagents
- 7.2.1 Overview
- 7.2.2 Reagents: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Asia-Pacific Blood Transfusion Diagnostics Market Analysis – by Application
8.1 Blood Grouping
- 8.1.1 Overview
- 8.1.2 Blood Grouping: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Disease Screening
- 8.2.1 Overview
- 8.2.2 Disease Screening: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Asia-Pacific Blood Transfusion Diagnostics Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Diagnostic Laboratories: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Blood Banks
- 9.3.1 Overview
- 9.3.2 Blood Banks: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Plasma Fractionation Companies
- 9.4.1 Overview
- 9.4.2 Plasma Fractionation Companies : Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Asia-Pacific Blood Transfusion Diagnostics Market – Asia-Pacific Analysis
10.1 Overview
10.2 Asia-Pacific
- 10.2.1 Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 China:
Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 China: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.1.2 China: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.1.3 China: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User
- 10.2.1.2 India:
Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 India: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.2.2 India: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.2.3 India: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User
- 10.2.1.3 Japan:
Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Japan: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.3.2 Japan: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.3.3 Japan: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User
- 10.2.1.4 Australia:
Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Australia: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.4.2 Australia: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.4.3 Australia: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User
- 10.2.1.5 Rest of Asia-Pacific :
Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
- 10.2.1.5.2 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
- 10.2.1.5.3 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BAG Diagnostics GmbH
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Bio-Rad Laboratories, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 DiaSorin S.p.A.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Grifols, S.A.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Immucor, Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Quotient Limited
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations